SL-353 (Meclizine 12.5 mg)

Pill imprint SL-353 has been identified as Meclizine hydrochloride 12.5 mg.

Meclizine is used in the treatment of vertigo; motion sickness; nausea/vomiting and belongs to the drug class anticholinergic antiemetics. There is no proven risk in humans during pregnancy. Meclizine 12.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for SL-353 (Meclizine 12.5 mg)

Meclizine hydrochloride 12.5 mg SL-353  Front
Meclizine hydrochloride 12.5 mg SL-353  Back
Meclizine hydrochloride
Imprint:
SL-353
Strength:
12.5 mg
Color:
White / Blue
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Anticholinergic antiemetics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sidmak
National Drug Code (NDC):
50111-0353

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web4)